Terray Therapeutics CEO Jacob Berlin (L) and CFO/COO Eli Berlin
Exclusive: Terray raises $120M for its AI ways of designing molecules
Terray Therapeutics has raised a $120 million Series B round, aiming to get its first drug candidate into the clinic while advancing in its AI …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
